HK Stock MarketDetailed Quotes
00690 UNI-BIO GROUP
- 0.090
- 0.0000.00%
Pre-Opening Auction Apr 19 09:00 CST
554.72MMarket Cap7.50P/E (TTM)
0.000High0.000Low0Volume0.000Open0.090Pre Close0.00Turnover0.00%Turnover Ratio7.50P/E (Static)6.16BShares0.10952wk High2.14P/B554.72MFloat Cap0.04152wk Low--Dividend TTM6.16BShs Float1.545Historical High--Dividend LFY0.00%Amplitude0.039Historical Low--Avg Price20000Lot Size--Div YieldTTM--Div Yield LFY
UNI-BIO GROUP Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 10.08%484.72M | 27.79%249.93M | 24.59%440.32M | 24.58%195.58M | 69.27%353.41M | 132.80%156.98M | -0.32%208.78M | -30.71%67.43M | 54.85%209.45M | 63.21%97.31M |
| Operating income | 10.08%484.72M | 27.79%249.93M | 24.59%440.32M | 24.58%195.58M | 69.27%353.41M | 132.80%156.98M | -0.32%208.78M | -30.71%67.43M | 54.85%209.45M | 63.21%97.31M |
| Cost of sales | 12.84%-91.9M | -0.02%-51.08M | -38.00%-105.43M | -56.95%-51.07M | -175.98%-76.4M | -221.57%-32.54M | 0.90%-27.68M | 38.59%-10.12M | -58.19%-27.93M | -105.87%-16.48M |
| Operating expenses | 12.84%-91.9M | -0.02%-51.08M | -38.00%-105.43M | -56.95%-51.07M | -175.98%-76.4M | -221.57%-32.54M | 0.90%-27.68M | 38.59%-10.12M | -58.19%-27.93M | -105.87%-16.48M |
| Gross profit | 17.30%392.82M | 37.61%198.85M | 20.89%334.88M | 16.12%144.51M | 52.96%277.01M | 117.13%124.44M | -0.23%181.09M | -29.10%57.31M | 54.35%181.52M | 56.59%80.84M |
| Selling expenses | -14.20%-241.28M | -48.55%-126.25M | -13.79%-211.27M | -11.67%-84.99M | -27.60%-185.67M | -78.86%-76.11M | 2.56%-145.52M | 41.63%-42.55M | -28.75%-149.34M | -22.55%-72.89M |
| Administrative expenses | -0.72%-47.38M | 0.96%-23.49M | 0.30%-47.04M | -6.38%-23.71M | -31.67%-47.18M | -13.89%-22.29M | 39.67%-35.83M | 35.22%-19.57M | 20.60%-59.39M | 24.31%-30.21M |
| Research and development expenses | 0.57%-35.58M | 51.72%-11.74M | 28.75%-35.78M | -13.80%-24.32M | -23.30%-50.22M | -164.62%-21.37M | 4.62%-40.73M | 36.03%-8.08M | 3.33%-42.7M | 12.40%-12.62M |
| Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --18.78M | --18.78M |
| Impairment and provision | ---- | ---- | 85.22%-2.31M | ---2.39M | ---15.61M | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | ---- | 85.22%-2.31M | ---2.39M | ---15.61M | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | 56.36%8.09M | 1.23%6.44M | 142.44%5.18M | 519.72%6.36M | 229.87%2.14M | -172.12%-1.52M | -115.51%-1.64M | -96.62%2.1M | 475.26%10.6M | 6,082.47%62.1M |
| Operating profit | 75.62%76.68M | 183.51%43.82M | 323.51%43.66M | 388.68%15.46M | 54.17%-19.54M | 129.34%3.16M | -5.14%-42.62M | -123.45%-10.78M | 70.66%-40.54M | 172.73%45.98M |
| Financing cost | -108.24%-783K | -154.17%-427K | 21.17%-376K | 38.46%-168K | -553.42%-477K | -0.74%-273K | 90.25%-73K | 54.45%-271K | -203.24%-749K | ---595K |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | -160.84%-28.25M | ---- | --46.43M | ---- |
| Earning before tax | 75.34%75.9M | 183.83%43.4M | 316.31%43.29M | 429.03%15.29M | 71.79%-20.01M | 126.15%2.89M | -1,480.18%-70.94M | -124.35%-11.05M | 103.71%5.14M | 171.79%45.39M |
| Tax | -5.21%-5.02M | -514.46%-3.99M | -1,234.20%-4.78M | 33.20%-650K | 211.38%421K | -140.25%-973K | 85.90%-378K | 17.68%-405K | -1,900.75%-2.68M | ---492K |
| After-tax profit from continuing operations | 84.04%70.88M | 169.15%39.4M | 296.58%38.51M | 663.64%14.64M | 72.53%-19.59M | 116.73%1.92M | -3,000.33%-71.32M | -125.52%-11.46M | 101.77%2.46M | 171.01%44.9M |
| Earning after tax | 84.04%70.88M | 169.15%39.4M | 296.58%38.51M | 663.64%14.64M | 72.53%-19.59M | 116.73%1.92M | -3,000.33%-71.32M | -125.52%-11.46M | 101.77%2.46M | 171.01%44.9M |
| Profit attributable to shareholders | 84.04%70.88M | 169.15%39.4M | 296.58%38.51M | 663.64%14.64M | 72.53%-19.59M | 116.73%1.92M | -3,000.33%-71.32M | -125.52%-11.46M | 101.77%2.46M | 171.01%44.9M |
| Basic earnings per share | 81.97%0.0111 | 169.57%0.0062 | 296.77%0.0061 | 666.67%0.0023 | 72.07%-0.0031 | 116.67%0.0003 | -2,875.00%-0.0111 | -124.66%-0.0018 | 101.79%0.0004 | 171.57%0.0073 |
| Diluted earnings per share | 81.97%0.0111 | 169.57%0.0062 | 296.77%0.0061 | 666.67%0.0023 | 72.07%-0.0031 | 116.67%0.0003 | -2,875.00%-0.0111 | -124.66%-0.0018 | 0.0004 | 171.57%0.0073 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg